RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 4 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,673,446 | -0.2% | 349,470 | -2.5% | 0.01% | +16.7% |
| Q2 2023 | $2,678,219 | +9.3% | 358,530 | -2.4% | 0.01% | 0.0% |
| Q1 2023 | $2,450,491 | -13.5% | 367,390 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $2,832,577 | -27.5% | 367,390 | 0.0% | 0.01% | -36.4% |
| Q3 2022 | $3,909,000 | +28.6% | 367,390 | -1.6% | 0.01% | +37.5% |
| Q2 2022 | $3,039,000 | +13.7% | 373,390 | 0.0% | 0.01% | +33.3% |
| Q1 2022 | $2,673,000 | -58.2% | 373,390 | 0.0% | 0.01% | -53.8% |
| Q4 2021 | $6,396,000 | -30.2% | 373,390 | -6.3% | 0.01% | -35.0% |
| Q3 2021 | $9,168,000 | – | 398,420 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 67,871 | $669,208 | 0.48% |
| GoalFusion Wealth Management, LLC | 20,000 | $197,200 | 0.13% |
| BALDWIN BROTHERS LLC/MA | 7,336 | $72,333 | 0.01% |
| EXCHANGE TRADED CONCEPTS, LLC | 16,359 | $161,300 | 0.00% |